Metraipolis › archive › dc_5ba5fbb3ebe1
Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis — Europe PMC PMID:42666138
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42666138
- DOI
- 10.3389/fonc.2026.1903922
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T14:08:27.540Z
- SHA-256 of the archived text
58ba2e54c9cbf0d386d9a7d66fb8156bdc4dab51b10889ecf0e8a7463fe12904- Stable URL of this page
https://metraipolis.com/documento/dc_5ba5fbb3ebe1
How to cite
Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis — Europe PMC PMID:42666138 — Europe PMC (en), https://europepmc.org/article/MED/42666138 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ba5fbb3ebe1 (Metraipolis archive dc_5ba5fbb3ebe1, sha256 58ba2e54c9cbf0d386d9a7d66fb8156bdc4dab51b10889ecf0e8a7463fe12904)
BibTeX
@misc{dc5ba5fbb3ebe1,
title = {Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis — Europe PMC PMID:42666138},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42666138},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ba5fbb3ebe1; sha256 58ba2e54c9cbf0d386d9a7d66fb8156bdc4dab51b10889ecf0e8a7463fe12904},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42666138. Agents can read the archived copy with the MCP tool read_document.